GRANDULYAR XEYLITNI DAVOLASH
Keywords:
Grandulyar xeylit, Granuloma, Yalligʻlanish, Immun tizimi, Infeksiyalar, Autoimmun kasalliklar, Kortikosteroidlar, AntibiotiklarAbstract
Grandulyar xeylit bu immun tizimining yalligʻlanishga javoban toʻqimalarda hosil boʻladigan patologik oʻsma boʻlib, u turli sabablarga (infeksiyalar, autoimmun kasalliklar, chet el jismlari) koʻra paydo boʻlishi mumkin. Ushbu maqolada grandulyar xeylitning patogenezi, sabablari, klinik belgilari, tashxislash va davolash usullari haqida batafsil maʼlumot keltirilgan.
References
1. Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins and Cotran Pathologic Basis of Disease (10th ed.). Elsevier.
2. James, W. D., Berger, T. G., & Elston, D. M. (2019). Andrews' Diseases of the Skin: Clinical Dermatology (13th ed.). Elsevier.
3. American Thoracic Society (ATS). (2020). Diagnosis and Treatment of Sarcoidosis. American Journal of Respiratory and Critical Care Medicine.
4. Makhmudovna, T. M., Shukhratovna, J. D., & Iskandarovna, D. M. (2024). THERAPY OF VITAL PULP OF PERMANENT TEETH WITH REVERSIBLE OR IRREVERSIBLE PULPITIS. International journal of artificial intelligence, 4(07), 293-295.
5. TOSHTEMIROVA, M., KIZI, M., BOZOROV, A. A., AKRAMOV, F., & XABIBJONOV, B. SHOULD ANTIBIOTICS BE USED IN COMPLEX THERAPY OF CHRONIC INFLAMMATORY PERIODONTAL DISEASES. Valeology: International Journal of Medical Anthropology and Bioethics.
6. Qizi, T. M. M., & Ugli, Y. S. M. (2023). IMPROVING THE TREATMENT OF PATHOLOGICALLY ALTERED DENTAL STATUS IN ELDERLY AND SENILE PEOPLE WITH PULMONARY TUBERCULOSIS. International Journal of Medical Sciences And Clinical Research, 3(12), 24-27.
7. G’ofurovich, J. A. TRUE PEMPHIGUS: PATHOGENESIS, DIAGNOSIS, TREATMENT Toshtemirova Mokhira Makhmud kizi.
Published
Issue
Section
License
Copyright (c) 2025 Toshtemirova Mokhira, Mamatov O'ktam, No'manov Bahodir, Xolmurodova Gulorom, Kuchiyeva Nargiza, Aslamov Og'abek (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All Rights Reserved.
